Schrodinger, Inc.

SDGRNasdaq· Pharmaceutical Preparations

Price History

Revenue

$255.9M

▲ 23.3% YoY

Net Income

-$103.3M

▲ 44.8% YoY

EPS

$-1.41

▲ 45.1% YoY

Cash

$230.5M

▲ 56.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.